Your browser doesn't support javascript.
loading
Lost in translation: Revisiting the use of tyrosine kinase inhibitors in colorectal cancer.
Iyer, Kirti K; van Erp, Nielka P; Tauriello, Daniele V F; Verheul, Henk M W; Poel, Dennis.
Afiliação
  • Iyer KK; Department of Medical Oncology, Radboud Institute for Health and Sciences, Radboud University Medical Centre, Nijmegen, The Netherlands; Department of Cell Biology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Centre, Nijmegen, The Netherlands. Electronic address: Kirti.
  • van Erp NP; Department of Pharmacy, Radboud Institute for Health and Sciences, Radboud University Medical Centre, Nijmegen, The Netherlands. Electronic address: Nielka.vanErp@radboudumc.nl.
  • Tauriello DVF; Department of Cell Biology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Centre, Nijmegen, The Netherlands. Electronic address: Daniele.Tauriello@radboudumc.nl.
  • Verheul HMW; Department of Medical Oncology, Radboud Institute for Health and Sciences, Radboud University Medical Centre, Nijmegen, The Netherlands. Electronic address: Henk.Verheul@radboudumc.nl.
  • Poel D; Department of Medical Oncology, Radboud Institute for Health and Sciences, Radboud University Medical Centre, Nijmegen, The Netherlands; Department of Cell Biology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Centre, Nijmegen, The Netherlands. Electronic address: Dennis
Cancer Treat Rev ; 110: 102466, 2022 Nov.
Article em En | MEDLINE | ID: mdl-36183569

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Inibidores de Proteínas Quinases Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Cancer Treat Rev Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Inibidores de Proteínas Quinases Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Cancer Treat Rev Ano de publicação: 2022 Tipo de documento: Article